Journal
BREAST CANCER RESEARCH AND TREATMENT
Volume 186, Issue 3, Pages 655-665Publisher
SPRINGER
DOI: 10.1007/s10549-021-06123-9
Keywords
Biomarker; Breast cancer; Cell cycle; Cell proliferation; Phosphoglycerate dehydrogenase
Categories
Funding
- National Medical Research Council of Singapore [NMRC/CIRG/1370/2013]
Ask authors/readers for more resources
This study found that PHGDH plays a regulatory role in breast cancer cell proliferation, and its expression is associated with tumor severity and patient prognosis. It may serve as a potential prognostic marker and therapeutic target in breast cancer.
Purpose Breast cancer is the most common type of cancer affecting women worldwide. Phosphoglycerate dehydrogenase (PHGDH) is an oxidoreductase in the serine biosynthesis pathway. Although it has been reported to affect growth of various tumors, its role in breast cancer is largely unknown. This study aimed to analyze the expression of PHGDH in breast cancer tissue samples and to determine if PHGDH regulates breast cancer cell proliferation. Methods Tissue microarrays consisting of 305 cases of breast invasive ductal carcinoma were used for immunohistochemical evaluation of PHGDH expression. The role of PHGDH in breast cancer was investigated in vitro by knocking down its expression and determining the effect on cell proliferation and cell cycling, and in ovo by using a chorioallantoic membrane (CAM) assay. Results Immunohistochemical examination showed that PHGDH is mainly localized in the cytoplasm of breast cancer cells and significantly associated with higher cancer grade, larger tumor size, increased PCNA expression, and lymph node positivity. Analysis of the GOBO dataset of 737 patients demonstrated that increased PHGDH expression was associated with poorer overall survival. Knockdown of PHGDH expression in breast cancer cells in vitro resulted in a decrease in cell proliferation, reduction in cells entering the S phase of the cell cycle, and downregulation of various cell cycle regulatory genes. The volume of breast tumor in an in ovo CAM assay was found to be smaller when PHGDH was silenced. Conclusion The findings suggest that PHGDH has a regulatory role in breast cancer cell proliferation and may be a potential prognostic marker and therapeutic target in breast cancer.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available